Skip to main content
Premium Trial:

Request an Annual Quote

First Genetic Trust Builds its Board

NEW YORK, Dec. 24 - First Genetic Trust said yesterday that it appointed Ken Thornton to its board of directors.

 

Thornton recently retired from IBM where, as the general manager for the public sector, he led the company's government, education, healthcare, and pharmaceuticals business operations.

 

He will assist First Genetic Trust as it ramps up its commercial operations, said the company's CEO Arthur Holden.

 


Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.